A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder

Publisher： Cambridge University Press

E-ISSN： 1601-5215|22|2|68-80

ISSN： 0924-2708

Source： Acta Neuropsychiatrica, Vol.22, Iss.2, 2010-04, pp. : 68-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

By  

Acta Neuropsychiatrica, Vol. 25, Iss. 5, 2013-03 ,pp. : 297-306

Cambridge University Press

Access to resources Recommend Favorite

Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone

By  

International Psychogeriatrics, Vol. 20, Iss. 6, 2008-12 ,pp. : 1245-1250

Cambridge University Press

Access to resources Recommend Favorite

Typical and atypical antipsychotics in bipolar disorder

By  

Acta Neuropsychiatrica, Vol. 12, Iss. 3, 2000-09 ,pp. : 115-119

Cambridge University Press

Access to resources Recommend Favorite

Computerised Cognitive Training for Older Persons With Mild Cognitive Impairment: A Pilot Study Using a Randomised Controlled Trial Design

By  

Brain Impairment, Vol. 12, Iss. 3, 2011-12 ,pp. : 187-199

Cambridge University Press

Access to resources Recommend Favorite

Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial

By  

Acta Neuropsychiatrica, Vol. 21, Iss. 6, 2009-12 ,pp. : 285-291

Cambridge University Press

Access to resources Recommend Favorite